Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarilumab PK Interaction with Simvastatin in RA
NCT02017639Phase 1Completed
- Sponsor
- Sanofi
- Start
- Jan 2014
- Primary completion
- Mar 2016
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 3
01
Overview
Phase 1, open-label, single-arm trial of sarilumab in rheumatoid arthritis (RA), sponsored by Sanofi. Primary endpoints: Area Under the Curve from zero to last measurable concentration and Area Under the Curve. Started Jan 2014; status: completed.
02
Drugs
sarilumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02017639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02017639.